Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.

Francesco SaccàRoberta LanzilloAlessio SignoriGiorgia T ManiscalcoElisabetta SignorielloSalvatore Lo FermoAnnamaria RepicePietro AnnovazziDamiano BaronciniMarinella ClericoEleonora BinelloRaffaella CerquaGiorgia MataluniSimona BonavitaLuigi LavorgnaIgnazio Roberto ZarboAlice LaroniSilvia RossiLorena Pareja GutierrezSara La GioiaBarbara FrigeniValeria BarcellaJessica FrauEleonora CoccoGiuseppe FenuValentina Torri ClericiArianna SartoriSarah RasiaCinzia CordioliAlessia Di SapioSimona PontecorvoRoberta GrassoCaterina BarrilàCinzia Valeria RussoSabrina EspositoDomenico IppolitoFrancesca BovisFabio GalloMaria Pia Sormani

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2018)

Several factors are associated with higher switch risk in patients starting a first-line therapy and could be integrated in the decision-making process of first treatment choice.

Keyphrases

end stage renal disease
multiple sclerosis
newly diagnosed
ejection fraction
chronic kidney disease
decision making
prognostic factors
peritoneal dialysis
stem cells
patient reported outcomes
mesenchymal stem cells
white matter